Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
Sheinfeld
J
J
Department of Surgery, Memorial-Sloan-Kettering Cancer Center, New York, New York.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D018237:Germinoma / Q000097:blood / Q000401:mortality / Q000473:pathology* / Q000556:secondary / Q000628:therapy; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009367:Neoplasm Staging; D009919:Orchiectomy; D011237:Predictive Value of Tests; D011379:Prognosis; D012074:Remission Induction; D012187:Retroperitoneal Space; D012307:Risk Factors; D012680:Sensitivity and Specificity; D015996:Survival Rate; D013736:Testicular Neoplasms / Q000097:blood / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D014057:Tomography, X-Ray Computed; D000509:alpha-Fetoproteins / Q000032:analysis
D014408:Biomarkers, Tumor; D006063:Chorionic Gonadotropin; D000509:alpha-Fetoproteins; D002945:Cisplatin